Literature DB >> 34422101

Outcomes following acute poor-grade aneurysmal subarachnoid bleed - Is early definitive treatment better than delayed management?

Adam Gittins1, Nick Talbott1, Ahmed A Gilani1, Greg Packer1, Richard Browne1, Randeep Mullhi1, Zaheed Khan1, T Whitehouse1, Antonio Belli2, Rajnikant L Mehta3, Fang Gao-Smith3, Tonny Veenith3.   

Abstract

BACKGROUND/
OBJECTIVE: Patients with poor-grade subarachnoid bleed (World Federation of Neurosurgical Societies grades 4-5) often improve their neurocognitive function months after their ictus. However, it is essential to explore the timing of intervention and its impact on long-term outcome. We compared the long-term outcomes between immediate management within 24 h and delayed management after 24 h in patients following poor-grade subarachnoid bleed.
METHODS: This was a retrospective population-based study, including patients with poor-grade subarachnoid bleed who received definitive management between 1 January 2011 and 31 December 2016 in a large tertiary neurocritical care unit. The primary outcome was adjusted odds ratio of favourable outcome (Glasgow Outcome Scale 4-5) for survivors at 12 months following discharge, as measured by the Glasgow Outcome Scale. The secondary outcomes included adjusted odds ratio of a favourable outcome at discharge, 3 months and 6 months following discharge and survival rate at 28 days, 3 months, 6 months and 12 months following haemorrhage.
RESULTS: A total of 111 patients were included in this study: 53 (48%) received immediate management and 58 (52%) received delayed management. The mean time delay from referral to intervention was 14.9 ± 5.8 h in immediate management patients, compared to 79.6 ± 106.1 h in delayed management patients. At 12 months following discharge, the adjusted odds ratio for favourable outcome in immediate management versus delayed management patients was 0.96 (confidence interval (CI) = 0.17, 5.39; p = 0.961). At hospital discharge, 3 months and 6 months, the adjusted odds ratio for favourable outcome was 3.85 (CI = 1.38, 10.73; p = 0.010), 1.04 (CI = 0.22, 5.00; p = 0.956) and 0.98 (CI = 0.21, 4.58; p = 0.982), respectively. There were no differences in survival rate between the groups at 28 days, 3 months, 6 months and 12 months (71.7% in immediate management group vs. 82.8% in delayed management group at 12 months, p = 0.163).
CONCLUSIONS: Immediate management and delayed management after poor-grade subarachnoid bleed are associated with similar morbidity and mortality at 12 months. Therefore, delaying intervention in poor-grade patients may be a reasonable approach, especially if time is needed to plan the procedure or stabilise the patient adequately. © The Intensive Care Society 2020.

Entities:  

Keywords:  Subarachnoid haemorrhage; aneurysm; critical care; neuroimaging; neurosurgery; stroke

Year:  2020        PMID: 34422101      PMCID: PMC8373283          DOI: 10.1177/1751143720946562

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  21 in total

1.  Poor-grade subarachnoid hemorrhage: is surgical clipping worthwhile?

Authors:  Sunil K Gupta; Rajesh K Ghanta; Rajesh Chhabra; Sandeep Mohindra; Suresh N Mathuriya; Kanchan K Mukherjee; Alok U Umredkar; Navneet Singla
Journal:  Neurol India       Date:  2011 Mar-Apr       Impact factor: 2.117

Review 2.  Timing of surgery for aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.

Authors:  Zhong Yao; Xin Hu; Lu Ma; Chao You; Min He
Journal:  Int J Surg       Date:  2017-11-28       Impact factor: 6.071

3.  Timing of aneurysm surgery.

Authors:  N F Kassell; C G Drake
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

Review 4.  Early endovascular treatment of subarachnoid hemorrhage.

Authors:  Jordi A Matias-Guiu; Carmen Serna-Candel
Journal:  Interv Neurol       Date:  2013-03

Review 5.  Critical care of poor-grade subarachnoid hemorrhage.

Authors:  Katja E Wartenberg
Journal:  Curr Opin Crit Care       Date:  2011-04       Impact factor: 3.687

6.  Management morbidity and mortality in grade IV and V patients with aneurysmal subarachnoid haemorrhage.

Authors:  V Seifert; H A Trost; D Stolke
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

7.  Treatment of poor-grade subarachnoid hemorrhage trial.

Authors:  D Mitra; B Gregson; V Jayakrishnan; A Gholkar; A Vincent; P White; P Mitchell
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-24       Impact factor: 3.825

8.  Poor-grade aneurysmal subarachnoid hemorrhage: outcome after treatment with urgent surgery.

Authors:  John D Laidlaw; Kevin H Siu
Journal:  Neurosurgery       Date:  2003-12       Impact factor: 4.654

Review 9.  European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage.

Authors:  Thorsten Steiner; Seppo Juvela; Andreas Unterberg; Carla Jung; Michael Forsting; Gabriel Rinkel
Journal:  Cerebrovasc Dis       Date:  2013-02-07       Impact factor: 2.762

10.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.